selegiline has been researched along with toloxatone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Agostinelli, E; Artico, M; Befani, O; Cirilli, R; Costi, R; Di Santo, R; Ferretti, R; Gallinella, B; La Torre, F; Meninno, T; Palmegiani, P; Roux, A; Turini, P | 1 |
| Alcaro, S; Befani, O; Bolasco, A; Chimenti, F; Chimenti, P; Fioravanti, R; Manna, F; Ortuso, F; Secci, D; Turini, P | 1 |
| Alcaro, S; Bolasco, A; Cardia, MC; Chimenti, F; Chimenti, P; Fioravanti, R; Manna, F; Ortuso, F; Rossi, F; Secci, D; Turini, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Legoabe, LJ; Petzer, A; Petzer, JP | 1 |
| Lourens, AC; Minders, C; Petzer, A; Petzer, JP | 1 |
| Mostert, S; Petzer, A; Petzer, JP | 2 |
| Petzer, A; Petzer, JP; Terre'Blanche, G; Van der Walt, MM | 1 |
| Legoabe, LJ; Petzer, A; Petzer, JP; Qhobosheane, MA | 1 |
| Efimova, J; Ivanovskii, S; Petzer, A; Petzer, JP; Shetnev, A; Shlenev, R; Tarasov, A | 1 |
| Legoabe, LJ; Meiring, L; Petzer, A; Petzer, JP | 1 |
| Dostert, P; Strolin Benedetti, M | 1 |
1 review(s) available for selegiline and toloxatone
| Article | Year |
|---|---|
Overview of the present state of MAO inhibitors.
Topics: Animals; Benzamides; Humans; Hydrazines; Isoquinolines; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Parkinson Disease; Phenethylamines; Piperidines; Selegiline; Structure-Activity Relationship | 1987 |
13 other study(ies) available for selegiline and toloxatone
| Article | Year |
|---|---|
Design, synthesis, and biological activities of pyrrolylethanoneamine derivatives, a novel class of monoamine oxidases inhibitors.
Topics: Drug Design; Kinetics; Models, Molecular; Molecular Structure; Monoamine Oxidase Inhibitors; Oxazolidinones; Piperazines; Piperidines; Pyrrolidines; Structure-Activity Relationship | 2005 |
Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.
Topics: Isoenzymes; Isomerism; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrazoles; Structure-Activity Relationship | 2007 |
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
Topics: Animals; Cattle; Drug Design; Humans; Models, Molecular; Molecular Conformation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrazoles; Substrate Specificity | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
α-Tetralone derivatives as inhibitors of monoamine oxidase.
Topics: Enzyme Activation; Humans; Models, Molecular; Monoamine Oxidase Inhibitors; Structure-Activity Relationship; Tetralones | 2014 |
Monoamine oxidase inhibitory activities of heterocyclic chalcones.
Topics: Antiparkinson Agents; Chalcones; HeLa Cells; Humans; Hydrocarbons, Fluorinated; Kinetics; Kynuramine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrroles; Structure-Activity Relationship; Thiophenes | 2015 |
Inhibition of monoamine oxidase by benzoxathiolone analogues.
Topics: Benzoxazoles; Humans; Inhibitory Concentration 50; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Protein Isoforms; Structure-Activity Relationship | 2016 |
Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
Topics: Humans; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Structure-Activity Relationship; Styrenes | 2017 |
The evaluation of 1,4-benzoquinones as inhibitors of human monoamine oxidase.
Topics: Benzoquinones; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2017 |
Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors.
Topics: Chemistry Techniques, Synthetic; Humans; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Quinazolinones; Structure-Activity Relationship | 2018 |
1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B.
Topics: Amino Acid Sequence; Antidepressive Agents; Benzenesulfonamides; Benzoates; Binding Sites; Drug Evaluation, Preclinical; Humans; Isomerism; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxadiazoles; Protein Binding; Protein Conformation; Structure-Activity Relationship; Sulfonamides; Zonisamide | 2019 |
The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase.
Topics: Humans; Indans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Parkinson Disease; Propylamines; Selegiline; Tetrahydronaphthalenes; Tyramine | 2022 |